Efficacy and safety of first-line combination therapy versus monotherapy for vitreoretinal lymphoma: a systematic review and meta-analysis

BACKGROUND: Vitreoretinal lymphoma (VRL) is usually treated with a combination of intraocular methotrexate (ioMTX), high-dose intravenous methotrexate (HD-MTX), or local radiotherapy (RT) as the first options. The effectiveness and safety of monotherapy like bruton’s tyrosine kinase inhibitors (BTKi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Jing, Peng, Xiaoyan, Wang, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664658/
https://www.ncbi.nlm.nih.gov/pubmed/37993841
http://dx.doi.org/10.1186/s12886-023-03226-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664658/
https://www.ncbi.nlm.nih.gov/pubmed/37993841
http://dx.doi.org/10.1186/s12886-023-03226-3

Ejemplares similares